コンパニオンアニマル用特殊医薬品のグローバル市場2024-2028:動物病院、ペットケアクリニック、薬局

【英語タイトル】Global Companion Animal Specialty Drugs Market 2024-2028

Technavioが出版した調査資料(IRTNTR44185-23)・商品コード:IRTNTR44185-23
・発行会社(調査会社):Technavio
・発行日:2023年10月23日
・ページ数:約120
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:北米、ヨーロッパ、アジア、その他地域
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥370,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

コンパニオンアニマル用特殊医薬品の世界市場 2024-2028コンパニオンアニマル用特殊医薬品市場は、2023年から2028年にかけて4億5,355万米ドルの成長が予測され、予測期間中のCAGRは6.68%で加速すると予測されています。当レポートでは、コンパニオンアニマル用特殊医薬品市場について、市場規模や予測、動向、成長促進要因、課題などの全体的な分析に加え、約25のベンダーを網羅したベンダー分析を掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、ペットの人間化の進展、疾病予防やペット保険に対する意識の高まり、コンパニオンアニマル人口の高齢化によって牽引されています。

Technavioのコンパニオンアニマル用特殊医薬品市場は以下のようにセグメント化されています。
流通チャネル別
- 動物病院
- ペットケアクリニック
- 薬局

製品別
- ワクチン
- 抗生物質
- 寄生虫駆除剤
- 飼料添加物
- その他

地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域(ROW)

本調査では、コンパニオンアニマル用特殊医薬品市場の今後数年間の成長を牽引する主な要因の一つとして、コンパニオンアニマル用特殊医薬品の充実を挙げています。また、コンパニオンアニマル用特殊医薬品市場におけるmとaの増加、コンパニオンアニマルの肥満の増加は、市場の大きな需要につながるでしょう。

コンパニオンアニマル用特殊医薬品市場に関するレポートは以下の分野をカバーしています。
- コンパニオンアニマル用特殊医薬品市場規模
- コンパニオンアニマル用特殊医薬品市場の予測
- コンパニオンアニマル用特殊医薬品市場の産業分析

本レポートでは、コンパニオンアニマル用特殊医薬品市場の主要ベンダーの詳細な分析を掲載しています。主要ベンダーには、Bayer AG, Beaphar Beheer BV, Bimeda Holdings Ltd., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Chanelle Pharma Group, Dechra Pharmaceuticals Plc, Elanco Animal Health Inc., Kyoritsuseiyaku Corp., LABORATORIOS CALIER S.A, Mars Inc., Merck and Co. Inc., Neogen Corp., Norbrook Laboratories Ltd., Tianjin ringpu bio-technology Co. Ltd., Vetoquinol SA, Virbac Group, Zenex Animal Health India Private Ltd., Zoetis Inc., and Orion Corp.などがあります。また、コンパニオンアニマル用特殊医薬品市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。当レポートでは、主要ベンダーの分析に加え、包括的な市場とベンダーの状況を掲載しています。
当調査会社は、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、総括する方法で、市場の詳細な姿を提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

1 エグゼクティブサマリー
2 市場状況
3 市場規模
4 過去の市場規模
5 ファイブフォース分析
6 コンパニオンアニマル用特殊医薬品の世界市場:流通チャネル別市場分析
7 コンパニオンアニマル用特殊医薬品の世界市場:製品別市場分析
8 顧客状況
9 地域別状況
10 推進要因・課題・動向
11 企業状況
12 企業分析
13 付録

❖ レポートの目次 ❖

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market by Geography
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Distribution Channel
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global – Market size and forecast 2023-2028 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2023-2028 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global companion animal specialty drugs market 2018 – 2022
o Exhibit 18: Historic Market Size – Data Table on global companion animal specialty drugs market 2018 – 2022 ($ million)
o 4.2 Distribution Channel Segment Analysis 2018 – 2022
o Exhibit 19: Historic Market Size – Distribution Channel Segment 2018 – 2022 ($ million)
o 4.3 Product Segment Analysis 2018 – 2022
o Exhibit 20: Historic Market Size – Product Segment 2018 – 2022 ($ million)
o 4.4 Geography Segment Analysis 2018 – 2022
o Exhibit 21: Historic Market Size – Geography Segment 2018 – 2022 ($ million)
o 4.5 Country Segment Analysis 2018 – 2022
o Exhibit 22: Historic Market Size – Country Segment 2018 – 2022 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2023 and 2028
• 6 Market Segmentation by Distribution Channel
o 6.1 Market segments
o Exhibit 30: Chart on Distribution Channel – Market share 2023-2028 (%)
o Exhibit 31: Data Table on Distribution Channel – Market share 2023-2028 (%)
o 6.2 Comparison by Distribution Channel
o Exhibit 32: Chart on Comparison by Distribution Channel
o Exhibit 33: Data Table on Comparison by Distribution Channel
o 6.3 Veterinary hospitals – Market size and forecast 2023-2028
o Exhibit 34: Chart on Veterinary hospitals – Market size and forecast 2023-2028 ($ million)
o Exhibit 35: Data Table on Veterinary hospitals – Market size and forecast 2023-2028 ($ million)
o Exhibit 36: Chart on Veterinary hospitals – Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Veterinary hospitals – Year-over-year growth 2023-2028 (%)
o 6.4 Pet care clinics – Market size and forecast 2023-2028
o Exhibit 38: Chart on Pet care clinics – Market size and forecast 2023-2028 ($ million)
o Exhibit 39: Data Table on Pet care clinics – Market size and forecast 2023-2028 ($ million)
o Exhibit 40: Chart on Pet care clinics – Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Pet care clinics – Year-over-year growth 2023-2028 (%)
o 6.5 Pharmacy stores – Market size and forecast 2023-2028
o Exhibit 42: Chart on Pharmacy stores – Market size and forecast 2023-2028 ($ million)
o Exhibit 43: Data Table on Pharmacy stores – Market size and forecast 2023-2028 ($ million)
o Exhibit 44: Chart on Pharmacy stores – Year-over-year growth 2023-2028 (%)
o Exhibit 45: Data Table on Pharmacy stores – Year-over-year growth 2023-2028 (%)
o 6.6 Market opportunity by Distribution Channel
o Exhibit 46: Market opportunity by Distribution Channel ($ million)
o Exhibit 47: Data Table on Market opportunity by Distribution Channel ($ million)
• 7 Market Segmentation by Product
o 7.1 Market segments
o Exhibit 48: Chart on Product – Market share 2023-2028 (%)
o Exhibit 49: Data Table on Product – Market share 2023-2028 (%)
o 7.2 Comparison by Product
o Exhibit 50: Chart on Comparison by Product
o Exhibit 51: Data Table on Comparison by Product
o 7.3 Vaccines – Market size and forecast 2023-2028
o Exhibit 52: Chart on Vaccines – Market size and forecast 2023-2028 ($ million)
o Exhibit 53: Data Table on Vaccines – Market size and forecast 2023-2028 ($ million)
o Exhibit 54: Chart on Vaccines – Year-over-year growth 2023-2028 (%)
o Exhibit 55: Data Table on Vaccines – Year-over-year growth 2023-2028 (%)
o 7.4 Antibiotics – Market size and forecast 2023-2028
o Exhibit 56: Chart on Antibiotics – Market size and forecast 2023-2028 ($ million)
o Exhibit 57: Data Table on Antibiotics – Market size and forecast 2023-2028 ($ million)
o Exhibit 58: Chart on Antibiotics – Year-over-year growth 2023-2028 (%)
o Exhibit 59: Data Table on Antibiotics – Year-over-year growth 2023-2028 (%)
o 7.5 Parasiticides – Market size and forecast 2023-2028
o Exhibit 60: Chart on Parasiticides – Market size and forecast 2023-2028 ($ million)
o Exhibit 61: Data Table on Parasiticides – Market size and forecast 2023-2028 ($ million)
o Exhibit 62: Chart on Parasiticides – Year-over-year growth 2023-2028 (%)
o Exhibit 63: Data Table on Parasiticides – Year-over-year growth 2023-2028 (%)
o 7.6 Feed additives – Market size and forecast 2023-2028
o Exhibit 64: Chart on Feed additives – Market size and forecast 2023-2028 ($ million)
o Exhibit 65: Data Table on Feed additives – Market size and forecast 2023-2028 ($ million)
o Exhibit 66: Chart on Feed additives – Year-over-year growth 2023-2028 (%)
o Exhibit 67: Data Table on Feed additives – Year-over-year growth 2023-2028 (%)
o 7.7 Others – Market size and forecast 2023-2028
o Exhibit 68: Chart on Others – Market size and forecast 2023-2028 ($ million)
o Exhibit 69: Data Table on Others – Market size and forecast 2023-2028 ($ million)
o Exhibit 70: Chart on Others – Year-over-year growth 2023-2028 (%)
o Exhibit 71: Data Table on Others – Year-over-year growth 2023-2028 (%)
o 7.8 Market opportunity by Product
o Exhibit 72: Market opportunity by Product ($ million)
o Exhibit 73: Data Table on Market opportunity by Product ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 75: Chart on Market share by geography 2023-2028 (%)
o Exhibit 76: Data Table on Market share by geography 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 77: Chart on Geographic comparison
o Exhibit 78: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2023-2028
o Exhibit 79: Chart on North America – Market size and forecast 2023-2028 ($ million)
o Exhibit 80: Data Table on North America – Market size and forecast 2023-2028 ($ million)
o Exhibit 81: Chart on North America – Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on North America – Year-over-year growth 2023-2028 (%)
o 9.4 Europe – Market size and forecast 2023-2028
o Exhibit 83: Chart on Europe – Market size and forecast 2023-2028 ($ million)
o Exhibit 84: Data Table on Europe – Market size and forecast 2023-2028 ($ million)
o Exhibit 85: Chart on Europe – Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on Europe – Year-over-year growth 2023-2028 (%)
o 9.5 Asia – Market size and forecast 2023-2028
o Exhibit 87: Chart on Asia – Market size and forecast 2023-2028 ($ million)
o Exhibit 88: Data Table on Asia – Market size and forecast 2023-2028 ($ million)
o Exhibit 89: Chart on Asia – Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on Asia – Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2023-2028
o Exhibit 91: Chart on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
o Exhibit 92: Data Table on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
o Exhibit 93: Chart on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
o 9.7 US – Market size and forecast 2023-2028
o Exhibit 95: Chart on US – Market size and forecast 2023-2028 ($ million)
o Exhibit 96: Data Table on US – Market size and forecast 2023-2028 ($ million)
o Exhibit 97: Chart on US – Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on US – Year-over-year growth 2023-2028 (%)
o 9.8 Germany – Market size and forecast 2023-2028
o Exhibit 99: Chart on Germany – Market size and forecast 2023-2028 ($ million)
o Exhibit 100: Data Table on Germany – Market size and forecast 2023-2028 ($ million)
o Exhibit 101: Chart on Germany – Year-over-year growth 2023-2028 (%)
o Exhibit 102: Data Table on Germany – Year-over-year growth 2023-2028 (%)
o 9.9 UK – Market size and forecast 2023-2028
o Exhibit 103: Chart on UK – Market size and forecast 2023-2028 ($ million)
o Exhibit 104: Data Table on UK – Market size and forecast 2023-2028 ($ million)
o Exhibit 105: Chart on UK – Year-over-year growth 2023-2028 (%)
o Exhibit 106: Data Table on UK – Year-over-year growth 2023-2028 (%)
o 9.10 China – Market size and forecast 2023-2028
o Exhibit 107: Chart on China – Market size and forecast 2023-2028 ($ million)
o Exhibit 108: Data Table on China – Market size and forecast 2023-2028 ($ million)
o Exhibit 109: Chart on China – Year-over-year growth 2023-2028 (%)
o Exhibit 110: Data Table on China – Year-over-year growth 2023-2028 (%)
o 9.11 Japan – Market size and forecast 2023-2028
o Exhibit 111: Chart on Japan – Market size and forecast 2023-2028 ($ million)
o Exhibit 112: Data Table on Japan – Market size and forecast 2023-2028 ($ million)
o Exhibit 113: Chart on Japan – Year-over-year growth 2023-2028 (%)
o Exhibit 114: Data Table on Japan – Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity by geography
o Exhibit 115: Market opportunity by geography ($ million)
o Exhibit 116: Data Tables on Market opportunity by geography ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 117: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 118: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 119: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 120: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 121: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 122: Matrix on vendor position and classification
o 12.3 Bayer AG
o Exhibit 123: Bayer AG – Overview
o Exhibit 124: Bayer AG – Business segments
o Exhibit 125: Bayer AG – Key news
o Exhibit 126: Bayer AG – Key offerings
o Exhibit 127: Bayer AG – Segment focus
o 12.4 Beaphar Beheer BV
o Exhibit 128: Beaphar Beheer BV – Overview
o Exhibit 129: Beaphar Beheer BV – Product / Service
o Exhibit 130: Beaphar Beheer BV – Key offerings
o 12.5 Bimeda Holdings Ltd.
o Exhibit 131: Bimeda Holdings Ltd. – Overview
o Exhibit 132: Bimeda Holdings Ltd. – Product / Service
o Exhibit 133: Bimeda Holdings Ltd. – Key offerings
o 12.6 Boehringer Ingelheim International GmbH
o Exhibit 134: Boehringer Ingelheim International GmbH – Overview
o Exhibit 135: Boehringer Ingelheim International GmbH – Business segments
o Exhibit 136: Boehringer Ingelheim International GmbH – Key news
o Exhibit 137: Boehringer Ingelheim International GmbH – Key offerings
o Exhibit 138: Boehringer Ingelheim International GmbH – Segment focus
o 12.7 Ceva Sante Animale
o Exhibit 139: Ceva Sante Animale – Overview
o Exhibit 140: Ceva Sante Animale – Product / Service
o Exhibit 141: Ceva Sante Animale – Key offerings
o 12.8 Dechra Pharmaceuticals Plc
o Exhibit 142: Dechra Pharmaceuticals Plc – Overview
o Exhibit 143: Dechra Pharmaceuticals Plc – Business segments
o Exhibit 144: Dechra Pharmaceuticals Plc – Key offerings
o Exhibit 145: Dechra Pharmaceuticals Plc – Segment focus
o 12.9 Elanco Animal Health Inc.
o Exhibit 146: Elanco Animal Health Inc. – Overview
o Exhibit 147: Elanco Animal Health Inc. – Product / Service
o Exhibit 148: Elanco Animal Health Inc. – Key offerings
o 12.10 LABORATORIOS CALIER S.A
o Exhibit 149: LABORATORIOS CALIER S.A – Overview
o Exhibit 150: LABORATORIOS CALIER S.A – Product / Service
o Exhibit 151: LABORATORIOS CALIER S.A – Key offerings
o 12.11 Mars Inc.
o Exhibit 152: Mars Inc. – Overview
o Exhibit 153: Mars Inc. – Product / Service
o Exhibit 154: Mars Inc. – Key news
o Exhibit 155: Mars Inc. – Key offerings
o 12.12 Merck and Co. Inc.
o Exhibit 156: Merck and Co. Inc. – Overview
o Exhibit 157: Merck and Co. Inc. – Business segments
o Exhibit 158: Merck and Co. Inc. – Key news
o Exhibit 159: Merck and Co. Inc. – Key offerings
o Exhibit 160: Merck and Co. Inc. – Segment focus
o 12.13 Neogen Corp.
o Exhibit 161: Neogen Corp. – Overview
o Exhibit 162: Neogen Corp. – Business segments
o Exhibit 163: Neogen Corp. – Key news
o Exhibit 164: Neogen Corp. – Key offerings
o Exhibit 165: Neogen Corp. – Segment focus
o 12.14 Norbrook Laboratories Ltd.
o Exhibit 166: Norbrook Laboratories Ltd. – Overview
o Exhibit 167: Norbrook Laboratories Ltd. – Product / Service
o Exhibit 168: Norbrook Laboratories Ltd. – Key offerings
o 12.15 Vetoquinol SA
o Exhibit 169: Vetoquinol SA – Overview
o Exhibit 170: Vetoquinol SA – Business segments
o Exhibit 171: Vetoquinol SA – Key news
o Exhibit 172: Vetoquinol SA – Key offerings
o Exhibit 173: Vetoquinol SA – Segment focus
o 12.16 Virbac Group
o Exhibit 174: Virbac Group – Overview
o Exhibit 175: Virbac Group – Business segments
o Exhibit 176: Virbac Group – Key news
o Exhibit 177: Virbac Group – Key offerings
o Exhibit 178: Virbac Group – Segment focus
o 12.17 Zoetis Inc.
o Exhibit 179: Zoetis Inc. – Overview
o Exhibit 180: Zoetis Inc. – Business segments
o Exhibit 181: Zoetis Inc. – Key news
o Exhibit 182: Zoetis Inc. – Key offerings
o Exhibit 183: Zoetis Inc. – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 184: Inclusions checklist
o Exhibit 185: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 186: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 187: Research methodology
o Exhibit 188: Validation techniques employed for market sizing
o Exhibit 189: Information sources
o 13.5 List of abbreviations
o Exhibit 190: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market by Geography
Exhibits5: Executive Summary – Chart on Market Segmentation by Distribution Channel
Exhibits6: Executive Summary – Chart on Market Segmentation by Product
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2023-2028 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2023-2028 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size – Data Table on global companion animal specialty drugs market 2018 – 2022 ($ million)
Exhibits19: Historic Market Size – Distribution Channel Segment 2018 – 2022 ($ million)
Exhibits20: Historic Market Size – Product Segment 2018 – 2022 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2018 – 2022 ($ million)
Exhibits22: Historic Market Size – Country Segment 2018 – 2022 ($ million)
Exhibits23: Five forces analysis – Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants – Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes – Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry – Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition – Five forces 2023 and 2028
Exhibits30: Chart on Distribution Channel – Market share 2023-2028 (%)
Exhibits31: Data Table on Distribution Channel – Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Distribution Channel
Exhibits33: Data Table on Comparison by Distribution Channel
Exhibits34: Chart on Veterinary hospitals – Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on Veterinary hospitals – Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on Veterinary hospitals – Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Veterinary hospitals – Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Pet care clinics – Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on Pet care clinics – Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on Pet care clinics – Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Pet care clinics – Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Pharmacy stores – Market size and forecast 2023-2028 ($ million)
Exhibits43: Data Table on Pharmacy stores – Market size and forecast 2023-2028 ($ million)
Exhibits44: Chart on Pharmacy stores – Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Pharmacy stores – Year-over-year growth 2023-2028 (%)
Exhibits46: Market opportunity by Distribution Channel ($ million)
Exhibits47: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits48: Chart on Product – Market share 2023-2028 (%)
Exhibits49: Data Table on Product – Market share 2023-2028 (%)
Exhibits50: Chart on Comparison by Product
Exhibits51: Data Table on Comparison by Product
Exhibits52: Chart on Vaccines – Market size and forecast 2023-2028 ($ million)
Exhibits53: Data Table on Vaccines – Market size and forecast 2023-2028 ($ million)
Exhibits54: Chart on Vaccines – Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Vaccines – Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on Antibiotics – Market size and forecast 2023-2028 ($ million)
Exhibits57: Data Table on Antibiotics – Market size and forecast 2023-2028 ($ million)
Exhibits58: Chart on Antibiotics – Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Antibiotics – Year-over-year growth 2023-2028 (%)
Exhibits60: Chart on Parasiticides – Market size and forecast 2023-2028 ($ million)
Exhibits61: Data Table on Parasiticides – Market size and forecast 2023-2028 ($ million)
Exhibits62: Chart on Parasiticides – Year-over-year growth 2023-2028 (%)
Exhibits63: Data Table on Parasiticides – Year-over-year growth 2023-2028 (%)
Exhibits64: Chart on Feed additives – Market size and forecast 2023-2028 ($ million)
Exhibits65: Data Table on Feed additives – Market size and forecast 2023-2028 ($ million)
Exhibits66: Chart on Feed additives – Year-over-year growth 2023-2028 (%)
Exhibits67: Data Table on Feed additives – Year-over-year growth 2023-2028 (%)
Exhibits68: Chart on Others – Market size and forecast 2023-2028 ($ million)
Exhibits69: Data Table on Others – Market size and forecast 2023-2028 ($ million)
Exhibits70: Chart on Others – Year-over-year growth 2023-2028 (%)
Exhibits71: Data Table on Others – Year-over-year growth 2023-2028 (%)
Exhibits72: Market opportunity by Product ($ million)
Exhibits73: Data Table on Market opportunity by Product ($ million)
Exhibits74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits75: Chart on Market share by geography 2023-2028 (%)
Exhibits76: Data Table on Market share by geography 2023-2028 (%)
Exhibits77: Chart on Geographic comparison
Exhibits78: Data Table on Geographic comparison
Exhibits79: Chart on North America – Market size and forecast 2023-2028 ($ million)
Exhibits80: Data Table on North America – Market size and forecast 2023-2028 ($ million)
Exhibits81: Chart on North America – Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on North America – Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Europe – Market size and forecast 2023-2028 ($ million)
Exhibits84: Data Table on Europe – Market size and forecast 2023-2028 ($ million)
Exhibits85: Chart on Europe – Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Europe – Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on Asia – Market size and forecast 2023-2028 ($ million)
Exhibits88: Data Table on Asia – Market size and forecast 2023-2028 ($ million)
Exhibits89: Chart on Asia – Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on Asia – Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
Exhibits92: Data Table on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
Exhibits93: Chart on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on US – Market size and forecast 2023-2028 ($ million)
Exhibits96: Data Table on US – Market size and forecast 2023-2028 ($ million)
Exhibits97: Chart on US – Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on US – Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on Germany – Market size and forecast 2023-2028 ($ million)
Exhibits100: Data Table on Germany – Market size and forecast 2023-2028 ($ million)
Exhibits101: Chart on Germany – Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on Germany – Year-over-year growth 2023-2028 (%)
Exhibits103: Chart on UK – Market size and forecast 2023-2028 ($ million)
Exhibits104: Data Table on UK – Market size and forecast 2023-2028 ($ million)
Exhibits105: Chart on UK – Year-over-year growth 2023-2028 (%)
Exhibits106: Data Table on UK – Year-over-year growth 2023-2028 (%)
Exhibits107: Chart on China – Market size and forecast 2023-2028 ($ million)
Exhibits108: Data Table on China – Market size and forecast 2023-2028 ($ million)
Exhibits109: Chart on China – Year-over-year growth 2023-2028 (%)
Exhibits110: Data Table on China – Year-over-year growth 2023-2028 (%)
Exhibits111: Chart on Japan – Market size and forecast 2023-2028 ($ million)
Exhibits112: Data Table on Japan – Market size and forecast 2023-2028 ($ million)
Exhibits113: Chart on Japan – Year-over-year growth 2023-2028 (%)
Exhibits114: Data Table on Japan – Year-over-year growth 2023-2028 (%)
Exhibits115: Market opportunity by geography ($ million)
Exhibits116: Data Tables on Market opportunity by geography ($ million)
Exhibits117: Impact of drivers and challenges in 2023 and 2028
Exhibits118: Overview on Criticality of inputs and Factors of differentiation
Exhibits119: Overview on factors of disruption
Exhibits120: Impact of key risks on business
Exhibits121: Vendors covered
Exhibits122: Matrix on vendor position and classification
Exhibits123: Bayer AG – Overview
Exhibits124: Bayer AG – Business segments
Exhibits125: Bayer AG – Key news
Exhibits126: Bayer AG – Key offerings
Exhibits127: Bayer AG – Segment focus
Exhibits128: Beaphar Beheer BV – Overview
Exhibits129: Beaphar Beheer BV – Product / Service
Exhibits130: Beaphar Beheer BV – Key offerings
Exhibits131: Bimeda Holdings Ltd. – Overview
Exhibits132: Bimeda Holdings Ltd. – Product / Service
Exhibits133: Bimeda Holdings Ltd. – Key offerings
Exhibits134: Boehringer Ingelheim International GmbH – Overview
Exhibits135: Boehringer Ingelheim International GmbH – Business segments
Exhibits136: Boehringer Ingelheim International GmbH – Key news
Exhibits137: Boehringer Ingelheim International GmbH – Key offerings
Exhibits138: Boehringer Ingelheim International GmbH – Segment focus
Exhibits139: Ceva Sante Animale – Overview
Exhibits140: Ceva Sante Animale – Product / Service
Exhibits141: Ceva Sante Animale – Key offerings
Exhibits142: Dechra Pharmaceuticals Plc – Overview
Exhibits143: Dechra Pharmaceuticals Plc – Business segments
Exhibits144: Dechra Pharmaceuticals Plc – Key offerings
Exhibits145: Dechra Pharmaceuticals Plc – Segment focus
Exhibits146: Elanco Animal Health Inc. – Overview
Exhibits147: Elanco Animal Health Inc. – Product / Service
Exhibits148: Elanco Animal Health Inc. – Key offerings
Exhibits149: LABORATORIOS CALIER S.A – Overview
Exhibits150: LABORATORIOS CALIER S.A – Product / Service
Exhibits151: LABORATORIOS CALIER S.A – Key offerings
Exhibits152: Mars Inc. – Overview
Exhibits153: Mars Inc. – Product / Service
Exhibits154: Mars Inc. – Key news
Exhibits155: Mars Inc. – Key offerings
Exhibits156: Merck and Co. Inc. – Overview
Exhibits157: Merck and Co. Inc. – Business segments
Exhibits158: Merck and Co. Inc. – Key news
Exhibits159: Merck and Co. Inc. – Key offerings
Exhibits160: Merck and Co. Inc. – Segment focus
Exhibits161: Neogen Corp. – Overview
Exhibits162: Neogen Corp. – Business segments
Exhibits163: Neogen Corp. – Key news
Exhibits164: Neogen Corp. – Key offerings
Exhibits165: Neogen Corp. – Segment focus
Exhibits166: Norbrook Laboratories Ltd. – Overview
Exhibits167: Norbrook Laboratories Ltd. – Product / Service
Exhibits168: Norbrook Laboratories Ltd. – Key offerings
Exhibits169: Vetoquinol SA – Overview
Exhibits170: Vetoquinol SA – Business segments
Exhibits171: Vetoquinol SA – Key news
Exhibits172: Vetoquinol SA – Key offerings
Exhibits173: Vetoquinol SA – Segment focus
Exhibits174: Virbac Group – Overview
Exhibits175: Virbac Group – Business segments
Exhibits176: Virbac Group – Key news
Exhibits177: Virbac Group – Key offerings
Exhibits178: Virbac Group – Segment focus
Exhibits179: Zoetis Inc. – Overview
Exhibits180: Zoetis Inc. – Business segments
Exhibits181: Zoetis Inc. – Key news
Exhibits182: Zoetis Inc. – Key offerings
Exhibits183: Zoetis Inc. – Segment focus
Exhibits184: Inclusions checklist
Exhibits185: Exclusions checklist
Exhibits186: Currency conversion rates for US$
Exhibits187: Research methodology
Exhibits188: Validation techniques employed for market sizing
Exhibits189: Information sources
Exhibits190: List of abbreviations



★調査レポート[コンパニオンアニマル用特殊医薬品のグローバル市場2024-2028:動物病院、ペットケアクリニック、薬局] (コード:IRTNTR44185-23)販売に関する免責事項を必ずご確認ください。
★調査レポート[コンパニオンアニマル用特殊医薬品のグローバル市場2024-2028:動物病院、ペットケアクリニック、薬局]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆